Detomidine hydrochloride is used as a sedative with analgesic properties, primarily licensed for use in horses. It produces dose-dependent sedative and analgesic effects by activating α2-adrenergic (catecholamine) receptors, leading to a negative feedback response that reduces the production of excitatory neurotransmitters. Due to its inhibition of the sympathetic nervous system, it also exhibits cardiac and respiratory effects as well as antidiuretic action.